SavedAdd your journal

Journals / International Journal of Secondary Metabolite / 2019 / Cilt: 6 - Sayı: 1

In vitro anticoagulant and antiinflammatory activities of Geastrum fimbriatum Fr., namely as Earthstar fungus

Tuba BAYGAR
Nurdan SARAÇ
Hakan ALLI
Aysel UĞUR
Pages
1–9
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, G. fimbriatum ethanolic extract exhibited potent antiinflammatory activity besides being a potential source of anticoagulant.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mushrooms have great potential to be used as food and pharmaceutical sources.
📊
Key Findings & Data:When compared with the negative control DMSO, G. fimbriatum extract exhibited significant anticoagulant effects in the APTT test that evaluates the intrinsic coagulation pathway.
💡
Conclusion & Impact:Overall, G. fimbriatum ethanolic extract exhibited potent antiinflammatory activity besides being a potential source of anticoagulant.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Medicinal mushroom · Lipoxygenase inhibition · Coagulation

Abstract

Mushrooms have great potential to be used as food and pharmaceutical sources. Most of the non-edible mushrooms contain biologically active metabolites that are functional for modern medicinal applications. Within the present study, anticoagulant and antiinflammatory activities of Geastrum fimbriatum Fr. (Syn. Geastrum sessile (Sowerby) Pouzar), a mushroom naturally grown in Turkey, were investigated. The in vitro anticoagulant activity of the ethanolic extract obtained with a soxhlet apparatus determined by activated partial thromboplastin time (APTT) and prothrombin time (PT) assays using commercial reagents. The antiinflammatory activity of the extract was determined by lipoxygenase inhibition assay. When compared with the negative control DMSO, G. fimbriatum extract exhibited significant anticoagulant effects in the APTT test that evaluates the intrinsic coagulation pathway. The ethanolic extract found to prolong the coagulation time. However, no inhibition was observed in the PT test which evaluates the extrinsic coagulation pathway, The extract showed 12.92% inhibition on the lipoxygenase enzyme activity. Overall, G. fimbriatum ethanolic extract exhibited potent antiinflammatory activity besides being a potential source of anticoagulant. Further analysis is required to evaluate the medical use of Geastrum mushrooms from a pharmaceutical point of view.

Özet

Mushrooms have great potential to be used as food and pharmaceutical sources. Most of the non-edible mushrooms contain biologically active metabolites that are functional for modern medicinal applications. Within the present study, anticoagulant and antiinflammatory activities of Geastrum fimbriatum Fr. (Syn. Geastrum sessile (Sowerby) Pouzar), a mushroom naturally grown in Turkey, were investigated. The in vitro anticoagulant activity of the ethanolic extract obtained with a soxhlet apparatus determined by activated partial thromboplastin time (APTT) and prothrombin time (PT) assays using commercial reagents. The antiinflammatory activity of the extract was determined by lipoxygenase inhibition assay. When compared with the negative control DMSO, G. fimbriatum extract exhibited significant anticoagulant effects in the APTT test that evaluates the intrinsic coagulation pathway. The ethanolic extract found to prolong the coagulation time. However, no inhibition was observed in the PT test which evaluates the extrinsic coagulation pathway, The extract showed 12.92% inhibition on the lipoxygenase enzyme activity. Overall, G. fimbriatum ethanolic extract exhibited potent antiinflammatory activity besides being a potential source of anticoagulant. Further analysis is required to evaluate the medical use of Geastrum mushrooms from a pharmaceutical point of view.

🔖

Cite This Article

BAYGAR, T., SARAÇ, N., ALLI, H., UĞUR, A. (2022). In vitro anticoagulant and antiinflammatory activities of Geastrum fimbriatum Fr., namely as Earthstar fungus. International Journal of Secondary Metabolite, Cilt: 6 - Sayı: 1, 1–9. https://ajindex.com/articles/541678

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Fares, A. (2013). Winter cardiovascular diseases phenomenon. N. Am. J. Med. Sci., 5, p.266-279
  2. WHO – World Health Organization. Cardiovascular diseases. http://www.who.int/mediacentre/factsheets/fs317/en/ 2015. (accessed 17.03.2016)
  3. Aguirre, J., Borgeat, A. (2013). Drugs for Thromboprophylaxis: Unfractionated Heparin, Low Molecular Weight Heparin, Warfarin, and Fondaparinux. In: Llau JV, editor. Thromboembolism in Orthopedic Surgery. Springer, London, England, p. 53-65
  4. Poulsen, B.K., Grove, E.L., Husted, S.E. (2012). New oral anticoagulants. Drugs, 72, p.1739-1753
  5. García-Lafuente, A., Guillamón, E., Villares, A., Rostagno, M.A., Martínez, J.A. (2009). Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res., 58, p.537-552
  6. Anilkumar, M. (2010). Ethnomedicinal plants as anti-inflammatory and analgesic agents. Ethnomedicine: A Source of Comp. Therap., p.267-293
  7. Amdekar, S., Roy, P., Singh, V., Kumar, A., Singh, R., Sharma, P. (2012). Anti-inflammatory activity of Lactobacillus on carrageenan-induced paw edema in male wistar rats. Int. J. Inflam., 2012, p. 752015
  8. Levick, S.P., Loch, D.C., Taylor, S.M., Janicki, J.S. (2007). Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J. Immunol., 178, p.641-646
  9. Rainsford, K.D. (2007). Anti-inflammatory drugs in the 21st century. Subcell Biochem., 42, p.3-27
  10. Samuelsson, B., Dahlén, S.E., Lindgren, J.Å., Rouzer, C.A., Serhan, C.N. (1987). Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science, 237, 1171-1176
  11. Yedgar, S., Krimsky, M., Cohen, Y., Flower, R.J. (2007). Treatment of inflammatory diseases by selective eicosanoid inhibition: A doubleedged sword? Trends Pharmacol. Sci., 28, p.459-464
  12. Czapski, G.A., Czubowicz, K., Strosznajder, R.P. (2012). Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacol. Rep., 64(5), p.1179-1188
  13. Ammon, H.P.T., Annazodo, M.I., Safayhi, H., Dhawan, B.N., Scrimal, R. (1992). Curcumin: a potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Med., 58, p.226
  14. Bensky, D., Gamble, A. (1986). Chinese Herbal Medicine: Materia Medica, 2nd edn. Seattle: Eastland Press
  15. Sullivan, R., Smith, J.E., Rowan, J., 2006. Medicinal mushrooms and cancer therapy: trans-lating a traditional practice into Western medicine. Perspect Bi